Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 421,993 shares of the company's stock, valued at approximately $5,672,000. Connor Clark & Lunn Investment Management Ltd. owned 0.17% of Oscar Health at the end of the most recent reporting period.
Other institutional investors have also bought and sold shares of the company. State Street Corp lifted its holdings in shares of Oscar Health by 6.0% during the third quarter. State Street Corp now owns 5,132,802 shares of the company's stock valued at $108,867,000 after acquiring an additional 291,335 shares during the period. Geode Capital Management LLC increased its position in shares of Oscar Health by 11.7% during the 3rd quarter. Geode Capital Management LLC now owns 4,339,640 shares of the company's stock worth $92,062,000 after purchasing an additional 455,205 shares in the last quarter. Hennessy Advisors Inc. lifted its holdings in Oscar Health by 550.3% during the 4th quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company's stock valued at $56,292,000 after purchasing an additional 3,544,300 shares during the last quarter. JPMorgan Chase & Co. boosted its position in Oscar Health by 68.5% in the third quarter. JPMorgan Chase & Co. now owns 2,309,150 shares of the company's stock valued at $48,977,000 after buying an additional 938,742 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in Oscar Health by 3.4% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,654,862 shares of the company's stock worth $22,241,000 after buying an additional 54,696 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company's stock.
Oscar Health Trading Up 0.0 %
Shares of NYSE OSCR traded up $0.01 during midday trading on Wednesday, hitting $12.84. The stock had a trading volume of 3,418,395 shares, compared to its average volume of 4,814,073. The firm has a market cap of $3.22 billion, a P/E ratio of -641.43 and a beta of 1.75. Oscar Health, Inc. has a fifty-two week low of $12.43 and a fifty-two week high of $23.79. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The company's 50-day simple moving average is $15.16 and its 200 day simple moving average is $16.31.
Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. Research analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current year.
Wall Street Analyst Weigh In
A number of research firms have recently issued reports on OSCR. Jefferies Financial Group assumed coverage on shares of Oscar Health in a research note on Tuesday, December 10th. They issued an "underperform" rating and a $12.00 target price for the company. Wells Fargo & Company downgraded Oscar Health from an "overweight" rating to an "equal weight" rating and cut their price objective for the company from $20.00 to $16.00 in a research report on Thursday, March 13th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $20.19.
View Our Latest Research Report on OSCR
About Oscar Health
(
Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
See Also
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
